Drug intelligence / Profile preview

Sodium iodide

Development stage: Phase 4
Modality: Small Molecules
Administration: Ophthalmic

Overview

Sodium iodide is an inorganic salt that functions as an antioxidant. It has been investigated for its role in preventing oxidative damage to the anterior part of the eye, particularly in the context of dry eye disease. Clinical trials have explored its effectiveness when applied topically, both with and without iontophoresis, to improve subjective and objective symptoms of moderate to severe dry eye.

Other names: sodium iodide

Targets

NIS (Human sodium iodide symporter)

Beyond the preview

Go deeper on Sodium iodide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium iodide.

Explore the full profile